Lexicon Pharmaceuticals Q4 Earnings Report Overview
Monday, 11 March 2024, 20:51
Lexicon Pharmaceuticals Q4 Earnings Report Overview
The latest financial report from Lexicon Pharmaceuticals for Q4 reveals that while the GAAP EPS came in line with expectations at -$0.20, the revenue of $0.7M missed estimates by $1.24M. Despite this revenue shortfall, the company maintains a strong financial position with $170.0M in cash and investments.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.